CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Contour Neurovascular Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03680742
NCT03680742N/ACompleted
CompareCT.gov

Contour Neurovascular System - European Pre-Market Unruptured Aneurysm Study (CERUS)

Cerus Endovascular, Inc.·interventional·Posted Sep 21, 2018·Updated Jun 23, 2021

In Brief

A clinical study evaluating Contour Neurovascular System for Intracranial Aneurysm. Completed, enrolled 34 participants across 6 sites in 3 countries.

Detailed Summary

Cerus Endovascular is sponsoring a prospective, multi-center trial to document the safety and performance of the Contour Neurovascular System™ ("Contour"). The purpose of the study is to document safety and performance of the Contour in treatment for patients with intracranial aneurysms (IA). The data from the study will be reported as a Pre-Market study to the Notified Body to support CE Mark approval.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysm
CountriesAustria, Denmark, Germany
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 21, 2018
Enrollment StartSep 18, 2018
Primary CompletionAug 10, 2020
Study CompletionFeb 2, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.8 years ago

Interventions

Contour Neurovascular Systemdevice

The Contour Neurovascular System™ is an intrasaccular, self-expanding, embolization device intended for the treatment of unruptured intracranial aneurysms.